论文部分内容阅读
Proteases (e.g., thrombin, metalloproteinase and cathepsin) have been screened as excellent biomarks for oncologic, cardiovascular, neurodegenerative, and inflammatory diseases, because of their aberrant activities in initiations and progressions of those diseases.